Expert Interview
A Second Opinion: Reviewing the top-line results of EyePoint's Phase II DAVIO 2 trial of EYP-1901 for wet-AMD
Ticker(s): EYPTInstitution: Johns Hopkins
- Professor and Chairman of Ophthalmology at Johns Hopkins Bayview Medical Center
- Manages 40 patients per week with geographic atrophy
- Teaches and conducts clinical research that has led to advances in the treatment of complex retinal detachments, vitreo-retinal complications of refractive surgery, diabetic retinopathy and age-related macular degeneration
Describe your background and practice setting
Added By: ben_adminWhat is your current treatment algorithm for patients with wet-AMD
Added By: ben_adminWhat are your thoughts on the potential of a sustained release delivery system for wet-AMD management?
Added By: ben_adminWhat are your thoughts on the recent data for EYP-1901?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
